Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bactrim Effect on Urinary Microbiome
NCT04230746Phase 1Withdrawn
- Sponsor
- Johns Hopkins University
- Start
- Oct 2023
- Primary completion
- Feb 2025
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, double-blind trial in urinary tract infection (UTI) comparing Placebo with Bactrim (2 arms). Primary endpoints: Change in Microbiome flora number of organisms at Day 180 and Change in Microbiome flora percentage distribution of organisms at Day 180. Planned start Oct 2023; status: withdrawn.
02
Drugs
trimethoprim + sulfamethoxazole
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on NCT04230746.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04230746.